Ethical violations in HPV vaccine trials, says committee

An Indian official committee has found ethical violations in HPV vaccine trials in India. Copyright: Flickr/kelsey*

Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

[NEW DELHI] An expert committee set up to investigate the conduct of studies using human papillomavirus (HPV) vaccines in India has reported large-scale ethical violations.

Members of the committee said since the project proposal involved research on human participants it should have followed "all the guidelines and statutory requirements applicable to research on human participants", the daily The Hindu reported.

Concern was expressed by members at unacceptable and prolonged delays in the reporting of adverse events and deaths, and a lack of independent monitoring systems.

"There has been direct contact with the human participants, they have administered an intervention which is not part of a prescribed prevention and have expected adverse events," members reported.

The committee comprised S.S. Aggarwal, former director of the Sanjay Gandhi Post-graduate Institute of Medical Sciences, S.P. Agarwal, former director-general of health services, and Suneeta Mittal, head of obstetrics and gynaecology at the All-India Institute of Medical Sciences (AIIMS) in New Delhi. They were assisted by a three-member sub-committee.

Members said there was a need for specific and separate legislation covering all aspects of biomedical and health research involving human participants and that statutory status should be given to the guidelines of the Indian Council of Medical Research.

Link to the original article in The Hindu